Las Vegas, NV -- (SBWIRE) -- 10/21/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: NiSource Inc. (NYSE:NI), KBR, Inc. (NYSE:KBR), Leap Wireless International, Inc. (NASDAQ:LEAP), Cell Therapeutics Inc (NASDAQ:CTIC)
NiSource Inc. (NYSE:NI) managed to keep its gain at 1.18% on below -normal volume of 1.73M shares. The stock settled at $31.68 after floating in a range of $31.34 to $31.84. Its latest price has reached market capitalization of $9.90 billion. Its 52-week range has been $23.14 to $31.84. NiSource Inc., an energy holding company, through its subsidiaries, provides natural gas, electricity, and other products and services.
For How Long NI will fight for Profitability? Read This Trend Analysis report
KBR, Inc. (NYSE:KBR) traded up on a volume of 1.73 million, higher than its standard daily volume. Shares have gained 2.50% to $35.65. Over the last twelve months, the stock has gained 15.82% and faced a worst price of $25.95. KBR, Inc. operates as an engineering, construction, and services company worldwide. The company?s Hydrocarbons segment designs and constructs liquefied natural gas and gas-to-liquids facilities; and delivers onshore and offshore oil and natural gas production facilities, including platforms, floating production and subsea facilities.
For How Long KBR’s Gloss will Attract Investors? Find out via this report
Leap Wireless International, Inc. (NASDAQ:LEAP) settled 0.50% higher at $15.96 on above-normal volume of 1.73M shares during the last trading day. The stock has its 12-month high at $17.51 and 52-week low price was $4.75. It traded in a range of $15.88 to $16.08 during the last trading day. Leap Wireless International, Inc., together with its subsidiaries, provides digital wireless services under the Cricket brand name in the United States. It offers unlimited local and the U.S. long distance services, and text messaging services, as well as mobile Web, 411, navigation, and data back-up services.
Why Should Investors Buy LEAP After the Recent Fall? Just Go Here and Find Out
In the last trading session, Cell Therapeutics Inc (NASDAQ:CTIC) was up on low volume, trading at a volume of 1.72M shares versus its average daily volume of 3.06 million shares. At $1.83, the stock has attained market capitalization of $210.04 million. Cell Therapeutics, Inc. engages in the acquisition, development, and commercialization of treatments for cancer.
Will CTIC Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)